Source: ERS Lung Science Conference 2016
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Martinez-Nunez (Southampton, United Kingdom). RibomiR-seq reveals microRNAs fine-tune the transcriptome but profoundly alter translation in severe asthma. ERS Lung Science Conference 2016

Member's Comments

No comment yet.

Related content which might interest you: The role of the regulated retrotransposon transcriptome in asthma Source: Annual Congress 2012 - New mechanisms in non-neoplastic and neoplastic lung diseases Year: 2012 Dysregulation of ZFP36L1 and ZFP36L2 in severe asthma alters epithelial integrity and dampens genome-wide glucocorticoid responses Source: Virtual Congress 2021 – Early manifestations of chronic respiratory disease: zooming in at the epithelial barrier Year: 2021 Glucocorticoid signaling genes are altered in asthma subgroups – A potential role for mRNA-miRNA interactions Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2020 MicroRNA profiling in bronchial biopsies identifies altered expression in asthma and high levels of allergen-modulated epithelial microRNAs Source: Virtual Congress 2021 – Early manifestations of chronic respiratory disease: zooming in at the epithelial barrier Year: 2021 Distinct epithelial phenotypes in child allergic respiratory disease are revealed by gene expression profiling Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 microRNA–mRNA regulatory networks underlying chronic mucus hypersecretion in COPD Source: Eur Respir J, 52 (3) 1701556; 10.1183/13993003.01556-2017 Year: 2018 In silico analysis of tuberculosis and multiple sclerosis gene expression profiles reveals coregulated genes implicated in host response to pathogens. Source: International Congress 2017 – Human susceptibility to tuberculosis Year: 2017 Transcription factors and miRNAs that regulate fetal to adult CFTR expression change are new targets for cystic fibrosis Source: Eur Respir J 2015; 45: 116-128 Year: 2015 Combined genome-wide transcriptomic and epigenetic profiling across disease stages identifies novel regulators of COPD in human lung fibroblasts Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020 Investigation for candidate genes of glucocorticoid resistance by genome-wide gene expression profiling in animal model of asthma Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 Global gene expression analyses highlight the role of plasma membrane remodeling as a molecular functions of airway epithelium in response to interleukin-13 treatment Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 PP103 – Dysregulation of ZFP36L1 and ZFP36L2 in asthma alters epithelial integrity and genome-wide glucocorticoid responses Source: ERS Lung Science Conference 2021 Year: 2021 Proteomic and genomic profiling to identify pathogenic mechanisms of inflammation, proteolysis and wasting in a murine COPD model Source: Eur Respir J 2004; 24: Suppl. 48, 104s Year: 2004 The role of post-transcriptional regulation in chemokine gene expression in inflammation and allergy Source: Eur Respir J 2005; 26: 933-947 Year: 2005 Understanding the regulation of surfactant gene expression Source: Eur Respir J 2003; 22: 6-7 Year: 2003 RNA-Seq transcriptome profiling of genes regulated by vitamin D in an asthma model Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Functional lower airways genomic profiling of the microbiome to capture active microbial metabolism Source: Eur Respir J, 58 (1) 2003434; 10.1183/13993003.03434-2020 Year: 2021 Profiling of airway epithelial proteome reveals sex differences in early stage COPD linked to xenobiotic metabolism and ER stress Source: Virtual Congress 2020 – Novel methods, diagnostics and biomarkers of chronic lung diseases Year: 2020 Benralizumab restored expression of key molecules involved in steroid-resistance in patients with severe asthma Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020